Patent Assignment
Reel/Frame 041385/0850
Assignment of Assignor's Interest
Recorded: 2017-02-27
Pages: 4
Assignee
TARGACEPT, INC.
200 EAST FIRST STREET, SUITE 300, WINSTON-SALEM, NORTH CAROLINA, 27101
Covered Properties
(4)
Arylvinylazacycloalkane Compounds and Methods of Preparation and Use Thereof
Arylvinylazacycloalkane Compounds and Methods of Preparation and Use Thereof
Arylvinylazacycloalkane Compounds and Methods of Preparation and Use Thereof
Application:
14/108,918 →
Publication:
US 2014/0107164
Arylvinylazacycloalkane Compounds and Methods of Preparation and Use Thereof
Application:
14/629,517 →
Publication:
US 2015/0164894
Related Assignments
(7)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 27, 2017
From: CATALYST BIOSCIENCES, INC.
To: OYSTER POINT PHARMA, INC.
Reel/Frame 041822/0678 →
Assignment of Assignor's Interest
Feb 27, 2017
From: AVENTIS PHARMA S.A.
To: TARGACEPT, INC.
Reel/Frame 041386/0202 →
Assignment of Assignor's Interest
Feb 27, 2017
From: GENEVOIS-BORELLA, ARIELLE; CAPET, MARC; CHEVE, MICHEL
To: AVENTIS PHARMA S.A.
Reel/Frame 041822/0587 →
Change of Name
Feb 27, 2017
From: TARGACEPT, INC.
To: CATALYST BIOSCIENCES, INC.
Reel/Frame 041822/0956 →
Patent Security Agreement
Aug 5, 2021
From: OYSTER POINT PHARMA, INC.
To: ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
Reel/Frame 057104/0189 →
Assignment of Assignor's Interest
Oct 26, 2021
From: SCHMITT, JEFFREY DANIEL; DULL, GARY MAURICE; MILLER, CRAIG HARRISON
To: TARGACEPT, INC.
Reel/Frame 057921/0023 →
Release of Security Interest
Feb 3, 2023
From: ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
To: OYSTER POINT PHARMA INC.
Reel/Frame 062582/0873 →